2025³â 08¿ù 05ÀÏ È­¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92443°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

»çȸ¹®Á¦¸¦ ÇØ°áÇϴ û³â 478¸íÀÇ ¡®º£À̽ºÄ·ÇÁ¡¯°¡ µÇ´Ù

10³â°£ 478¸íÀÇ ¼ö·á»ý ¹èÃ⡦ ÀÓÆÑÆ® »ýŰè ÀÎÀç µî¿ë¹® ¿ªÇÒ
ºñ¿µ¸® »ç´Ü¹ýÀÎ ·çÆ®ÀÓÆÑÆ®°¡ ‘ÀÓÆÑÆ® º£À̽ºÄ·ÇÁ(Impact Basecamp)’ ÇÁ·Î±×·¥ 10ÁÖ³âÀ» ¸Â¾Æ ¼ö·á»ýÀÇ º¯È­¿Í ÇÁ·Î±×·¥ÀÇ ¼º°ú¸¦ ´ãÀº ÀÓÆÑÆ® ¸®Æ÷Æ®¸¦ ¹ß°£ÇÏ°í ±â³äÇà»ç¸¦ °³ÃÖÇß´Ù. ÀÓÆÑÆ® º£À̽ºÄ·ÇÁ´Â û³âµéÀÌ »çȸ¹®Á¦¸¦ ÇØ°áÇÏ´Â ¿ª·®À» ±â¸£°í, À̸¦ Ä¿¸®¾î ¼ºÀå°ú ¿¬°èÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÏ´Â ±³À° ÇÁ·Î±×·¥ÀÌ´Ù. ¾à 8ÁÖ~16ÁÖ°£ »çȸ¹®Á¦¸¦ Á¤ÀÇÇϰí Á÷Á¢ ¹®Á¦ ÇØ°á ¹æ¹ýÀ» µµÃâÇÏ´Â ÇÁ·ÎÁ§Æ® ±â¹Ý ÇнÀ(Project Based Learning, PBL) ¹æ½ÄÀ¸·Î ÁøÇàµÈ´Ù. 2015³â ½ÃÀÛÇÑ ÀÌ·¡ ÇöÀç±îÁö 478¸íÀÇ ¼ö·á»ýÀ» ¹èÃâ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
LG CNS, AI ¼®»ç°úÁ¤ Çкñ Àü¾× Áö¿øÇϰí ÀԻ絵 º¸Àå (2024-01-02)
ÇÑÄÄ¿ÀÇǽº¿¡ °æ±âµµ ¼­Ã¼ žÀçŰ·Î °è¾à (2017-06-26)
ÄöÅÒ´å SUHD TV, ¼­³²¾Æ ÇÁ¸®¹Ì¾ö TV ½ÃÀå °ø·« (2016-10-14)
°æ±â ±¤ÁÖ¡¤ÀüºÏ ±º»ê µî ¹°·ù´ÜÁö 4°³¼Ò ½Å±Ô ÁöÁ¤ (2017-01-23)
¾ó±¼ÀÎ½Ä º¸¾È ¼­ºñ½º ¡®ÆäÀ̽ºÄ°¡¯ ÇÒÀÎ (2015-06-16)
ÁóÀå Á¦Á¶±â´É º¸À¯ ¹éÁ¤ÀÚ ¾¾, ´ëÇѹα¹ ½Äǰ¸íÀÎ ÁöÁ¤ (2015-09-25)
LG ANNOUNCES SECOND-QUARTER 2015 FINANCIAL RESULTS (2015-07-29)
´ÚÅͺ§¸Ó ºñŸ ¼¼¸° Åæ°á ¼¼·³ - ºñŸ¹Î ¿¡µð¼Ç (2020-04-20)
NTT and NTT DATA Roar into the Indianapolis 500 with AI-powe... (2024-05-30)
ûÃῬ±¸¼Ò ÄÃóÇ÷¯½º, ¼Óº¸ÀÌ´Â ÀλýÄ·ÇÁ ¾¾½º·ç (2017-10-14)
Àá½Ç¿¤½º, ÀÔÁÖ 6³â Â÷ ¸Â¾Æ ÀÓ´ë ¸Å¹° ½ñ¾ÆÁ® (2014-10-08)
Ãß°æÆí¼ºÀ¸·Î ±¹¹Î¾ÈÀü °­È­ (2017-07-24)
'Àú Çϴÿ¡ žçÀÌ' ¹Ú°æÇý, Ç¥Á¤ ġƮŰ µî±Ø (2016-10-13)
°í»ý¿¹´É Àü¹® ¡®¿ÀÁöÀÇ ¸¶¹ý»ç¡¯ ´Ï¿¤, Àå»çµµ ÀßÇØ (2017-06-25)
ÇØ¿Ü ¼ÒºñÀÚ 94.2% ÇѽĿ¡ ¡®¸¸Á·¡¯ (2023-07-27)
Á¤ºÎ Áö¿ø Àçâ¾÷ ±â¾÷ 3³â »õ 2¹è Áõ°¡ (2016-11-06)
GS¼¥, 1~2ÀÎ °¡±¸ °Ü³ÉÇÑ ¡®¼ÒÇü °ÇÁ¶±â¡¯ ÆÇ¸Å (2022-11-09)
´ë¿õÁ¦¾à ¡®³ªº¸Å¸¡¯ ¹Ì±¹¿¡¼­ ÆíµÎÅë Ä¡·á ƯÇã (2023-09-13)
Å×Çì¶õ·Î Á¦2Áö±¸ Áö±¸´ÜÀ§°èȹ ¡®¼öÁ¤°¡°á¡¯ (2016-08-25)
³ë¸£¿þÀÌ ¼ö»ê¹° ¼öÀÔ, Àü³â ´ëºñ 84% Áõ°¡ (2015-01-11)
LGÀüÀÚ, ÃÊÀýÀü ½ºÅĵåÇü ÀιöÅÍ Á¤¼ö±â Ãâ½Ã (2015-09-23)
Çö´ëÀÚµ¿Â÷-±â¾Æ, EV Æ®·»µå ÄÚ¸®¾Æ 2024 Âü°¡ (2024-03-09)
½ÅÀÎ °É±×·ì '¿¡À̽õå' Á÷Á¢ ¿ôã»ç-·¹Á¯µå ¸ÅÄ¡ ÀÀ¿ø (2017-05-31)
¿ÀÇǽºÅÚ °øµ¿±¸¸Å ½Ã´ë ¿¬´Ù (2016-06-28)
ÇÑÀü, µµ½ÉÁö Àü·Â¼³ºñ Á¤ºñ»ç¾÷ ÃßÁø (2016-10-07)
       [ÀÌÀü][1]....[1331][1332][1333][1334][1335][1336][1337][1338][1339]...[3698][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..